Induced pluripotent stem cells

CME Webinar: UNDERSTANDING STEM CELL THERAPIES IN PD: THE ROAD AHEAD | Claire Henchcliffe, M.D., D.Phil. | Tuesday, April 27, 2021 | 5:00-7:00pm PDT

ABOUT SUMMIT’S CME WEBINARS:

  • MDs, PAs, RNs
    TWO Category 1 CME Credits
  • LIVE Webinar
  • Registration Fee: $35.00
  • Panel discussion with LIVE Q & A following Presentations
  • Physicians, Patients, Researchers, Students    – Everyone is welcome!

    (Note: Content subject to change)

Guest Speaker:
Claire Henchcliffe, M.D., D.Phil. 

Chair, University California Irvine Dept. of Neurology

Meet Dr. Henchcliffe: Dr. Henchcliffe is the Chair and Stanley van den Noort Professor of Neurology, at the University of California, Irvine. She completed neurology residency and fellowship at the College of Physicians and Surgeons of Columbia University in New York City, prior to joining Weill Cornell Medical College, New York City in 2003 as Assistant Professor. At Weill Cornell Medical College she developed a clinical and research program in Parkinson’s disease with a focus on clinical trials including stem cell-based therapeutics, eventually serving as Professor of Neurology and Neuroscience, and Vice Chair for Clinical Research.

Dr. Henchcliffe’s Abstract: 
Rapid advances in stem cell biology have provided great optimism for the potential for human pluripotent stem cell-based therapies in Parkinson’s disease (PD). With trailblazing clinical trials starting in the 1980’s came the realization that new sources of purity high quality cells are a critical need. This presentation will focus on overcoming these barriers, and how cell replacement therapy in PD has been thrust to the forefront of regenerative medicine. In particular we will discuss the future trajectory and broader scope of what is needed for those with PD, including individualized treatment, enhancing safety, and long term follow up. 

Moderator:
Jeanne F. Loring, Ph.D.


Board Director & Chief Science Officer,
Summit for Stem Cell Foundation

Jeanne F. Loring is the Professor Emeritus at the Scripps Research Institute where she was founding Director of the Center for Regenerative Medicine. She is also founder of two stem cell-based biotechnology companies, Arcos Bioscience (now part of Viacyte) and Aspen Neuroscience, a biotechnology company developing a neuron replacement therapy for Parkinson disease. Dr. Loring has more than 30 years of experience in both biotechnology and academic research, focusing on stem cells, genomics, embryology and neurobiology. She holds five patents on stem cells and genomics, and has published more than 100 research articles in scientific journals that have been cited in scientific publications more than 14,000 times. She serves on both scientific advisory and bioethics boards, and advises governmental and private granting agencies in several countries. Through her laboratory courses, she has trained more than 400 scientists in stem cell technology.

In addition to her work on Parkinson disease, Dr. Loring investigates multiple sclerosis and autism, and works with the San Diego Zoo Institute for Conservation Research in an effort to rescue the Northern white rhinoceros from extinction using stem cell technology. She is also involved in a project on the International Space Station to study neurogenerative disease.

Dr. Loring is an advocate for patients and an outspoken critic of stem cell clinics that operate outside of ethical or scientific oversight. She speaks out against unregulated stem cell therapies that have caused severe injuries and even death, and the clinics who convince desperately ill patients to pay for treatments that are not effective.

Refund Policy

If you are unable to attend a LIVE webinar, you may cancel up to the scheduled time of the event and receive a full refund. No refunds or exchanges for On-Demand Recoded Webinars. (Not yet available.) Refunds or exchanges for a LIVE webinar will not be given for no shows. As an alternative to a refund, you can substitute a registration for a future live webinar or have your fee converted to a tax deductible donation.

You must contact [email protected] to request a refund or move your registration to another webinar or to a donation. Cancelling your registration through GoToWebinar will NOT process a refund – you MUST contact Summit for Stem Cell Foundation at [email protected].

In the rare event that a webinar is cancelled or postponed due to unanticipated circumstances, registrants will be notified immediately and given the opportunity to either transfer their registration to another webinar or obtain a refund.

This policy supersedes all other policies regarding the LIVE CME Webinar series.